Aleafia Health Inc ALEAF

Healthcare Cannabis

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.

GREY:ALEAF - Post by User

Aleafia Health Inc > $22.7 Million raised at $0.83 ! Still a deal here :) $$$$

<< Previous

Bullboard Posts

Next >>

Comment by ShakngMyHead00on Apr 02, 2021 10:49am

59 Views

Post# 32931878

RE:RE:RE:$22.7 Million raised at $0.83 ! Still a deal here :) $$$$

Cannabasis wrote: I like your stamina xD
1hot-techwoman wrote:
1hot-techwoman wrote:
Aleafia Health Announces Closing of $22.7 Million Bought Deal Offering

Tuesday, March 9, 2021, 9:21 AM ET

Aleafia Health Announces Closing of $22.7 Million Bought Deal Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TORONTO, March 09, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) ("Aleafia Health" or the "Company") is pleased to announce that it has closed its previously announced bought deal offering (the "Offering") for a total issuance of 27,390,000 units of the Company ("Units") at a price per Unit of $0.83 for gross proceeds of $22.7 million, which includes a partial exercise of the over-allotment option. The offering was led by Cantor Fitzgerald Canada Corporation, as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters including Echelon Wealth Partners Inc. and Mackie Research Capital Corp. (together, the "Underwriters").

:)